Replies to post #211573 on Biotech Values

[DewDiligence]

CGEN +19% on a (mere) patent issuance:

https://finance.yahoo.com/news/compugen-announces-issuance-u-patent-110000445.html

…U.S. Patent No. 9,714,289, relates to the method of using COM701 for activating T cells in cancer patients... The patent is expected to expire no earlier than February 2036 in the U.S.